paradigm
rna
viral
variat
alway
influenza
viru
reflect
need
annual
vaccin
yet
recogn
hiv
variat
far
extens
influenza
exampl
variat
hiv
envelop
protein
gpl
year
aid
epidem
threefold
greater
genet
drift
associ
analog
haemagglutinin
hong
kong
flu
observ
last
year
state
affair
number
factor
imping
upon
rna
retrovir
genet
variat
although
mutat
rate
error
per
base
replic
cycl
may
chang
vari
littl
factor
exampl
rna
perhap
five
eightfold
greater
retrovirus
obvious
mutat
occur
select
winnow
field
genet
variant
protein
accumul
fix
substitut
less
easili
other
exampl
surfac
envelop
protein
fix
substitut
approxim
time
faster
siv
integras
protein
compar
situat
pertain
influenza
haemagglutinin
neuraminidas
envelop
protein
fix
mutat
faster
either
capsid
nonstructur
protein
signal
except
hepat
b
viru
surfac
protein
hbsag
vari
surprisingli
littl
probabl
due
fact
correspond
gene
overlap
hiv
polymeras
restrict
number
viabl
permut
would
help
explain
low
frequenc
subunit
vaccin
escap
variant
otherwis
commonplac
perhap
import
factor
accumul
mutat
number
consecut
round
replic
way
maintain
parlanc
biolog
viru
influenza
viru
provok
acut
infect
limit
number
replic
cycl
immun
system
wipe
infect
within
short
window
viru
transmit
howev
transmiss
occur
face
partial
immun
host
seen
least
epitop
previou
year
although
littl
known
viral
dynam
influenza
infect
viru
spread
within
partli
immun
individu
presum
less
within
naiv
individu
inde
heighten
virul
associ
antigen
shift
may
understood
manner
transmiss
acut
natur
influenza
mean
larg
number
short
infect
chain
establish
parallel
virtual
come
end
result
clearanc
immun
system
new
epidem
essenti
origin
novel
clonal
variant
evidenc
genet
homogen
viru
crosssect
studi
hiv
situat
differ
infect
usual
initi
singl
virion
rapidli
prolifer
throughout
naiv
individu
invad
part
immun
system
within
day
immun
system
clear
viru
complet
infect
persist
virion
shed
clear
daili
rise
late
stage
diseas
although
hiv
transmiss
much
lower
influenza
handicap
made
persist
natur
hiv
infect
present
aid
pandem
proof
strategi
viabl
mani
parallel
chain
time
may
long
traceabl
current
genet
method
probabl
import
featur
distinguish
hiv
human
influenza
infect
fact
long
chain
infect
set
hiv
lead
enorm
crosssect
divers
fact
two
exampl
coalesc
context
influenza
infect
sever
immun
compromis
patient
may
persist
antigen
distinct
variant
shed
cours
infect
emphas
point
persist
rna
viral
infect
associ
extens
crosssect
genet
variabl
one
need
take
look
human
hepat
c
bovin
foot
mouth
diseas
virus
find
abund
variat
despit
wealth
genet
variabl
evid
de
novo
genet
variat
respons
either
hiv
persist
onset
aid
inde
persist
mere
toehold
extrem
hostil
world
rna
retrovir
infect
achiev
mechan
gener
variat
inde
probabl
safe
say
exampl
genet
stabil
accompani
persist
rna
viral
retrovir
infect
indic
special
virolog
particular
relationship
host
host
cell
restrict
variabl
hbsag
allud
remark
genet
stabil
human
tcefl
leukaemia
viru
type
accumul
mutat
scale
per
millennium
anoth
case
point
retroviru
infect
exactli
tcell
hiv
replic
predominantli
proviru
host
cell
mitosi
rare
via
revers
transcript
larg
popul
size
frequent
excess
error
prone
replic
realm
error
per
genom
obviou
rna
retroviru
sampl
consist
popul
genet
heterogen
genom
consequ
properti
influenc
fit
differ
select
popul
viral
genom
refer
viral
quasispeci
simpli
quasispeci
model
mathemat
receiv
biolog
confirm
cultur
viral
quasispeci
show
mani
featur
classic
popul
genet
includ
competit
exclus
principl
red
queen
hypothesi
muller
ratchet
fit
select
ominipres
system
essentiali
determinist
soon
microenviron
virolog
nich
chang
popul
rapidli
adjust
result
fit
select
variant
best
adapt
new
nich
properti
quasispeci
differ
vivo
question
appropri
viru
cultur
lack
viral
predat
also
spatial
homogen
vivo
wrath
innat
acquir
immun
appar
dynam
hiv
infect
virion
infect
cell
clear
per
day
fact
vast
major
viru
elimin
infect
sustain
small
fraction
immun
system
exquisit
spatial
organ
antibodi
antigen
specif
tcell
pour
clonal
oligoclon
site
peripheri
gener
polyclon
respons
hw
infect
tcell
lymphoblast
mainli
found
lymphoid
organ
distribut
therein
reflect
exquisit
spatial
heterogen
consequ
virion
variant
free
diffus
therefor
compet
quasispeci
descript
inadequ
come
infect
vivo
chiefli
host
order
magnitud
complic
tissu
cultur
flask
howev
model
invalu
concentr
attent
problem
rna
viral
evolut
nowher
help
understand
drug
resist
applic
drug
chang
local
optimum
domin
variant
longer
fittest
allow
outgrowth
drug
resist
form
definit
better
adapt
new
nich
obviou
larger
viral
popul
size
moment
drug
administr
greater
probabl
select
drug
resist
form
born
find
azt
resist
detect
earlier
among
patient
advanc
diseas
oppos
asymptomat
infect
viral
load
number
variant
greater
symptomat
oppos
asymptomat
infect
case
nevirapin
revers
transcriptas
drug
resist
involv
singl
substitut
emerg
within
day
vivo
case
resist
variant
probabl
present
within
pretreat
viral
quasispeci
full
azt
resist
five
substitut
necessari
hiv
quasispeci
vivo
ex
vivo
suffici
larg
encod
variant
howev
azt
resist
emerg
stepwis
manner
increas
resist
virtual
step
although
multipl
mutat
also
detect
respons
antiproteas
inhibitor
coupl
seem
confer
strong
resist
whole
point
success
multidrug
therapi
reduc
probabl
occurr
variant
resist
drug
use
less
reciproc
effect
popul
size
product
infect
cell
latter
paramet
present
unknown
howev
upper
limit
number
permiss
cell
bodi
x
tcell
bodi
seroneg
patient
factor
multipl
hiv
copi
per
cell
infect
macrophag
caveat
even
aid
patient
tcell
infect
x
u
popul
size
appear
around
arm
mutat
fixat
rate
possibl
calcul
minimum
popul
size
drug
resist
variant
emerg
stark
truth
scienc
unabl
calcul
anyth
precis
howev
ballpark
estim
made
follow
let
us
assum
three
drug
reason
pharmacolog
low
toxic
devoid
antagon
requir
singl
point
mutat
confer
full
resist
probabl
get
variant
simultan
resist
three
x
x
yet
less
invers
x
u
hiv
variant
popul
size
around
thu
viral
control
possibl
without
problem
resist
despit
host
caveat
concern
distinct
mutat
fixat
rate
unequ
mutat
frequenc
problem
toxic
complianc
etc
calcul
serv
emphas
variat
therapi
inevit
achil
heel
unavoid
side
unfortun
one
present
cost
combin
therapi
bulk
present
futur
hiv
infect
iswil
develop
world
least
present
polit
climat
unlik
fund
avail
suffici
rapidli
contain
pandem
new
although
hiv
surviv
replic
close
error
catastroph
might
well
push
societi
edg
